II
DNA icon

Inspire Investing’s Ginkgo Bioworks DNA Stock Holding History

Inspire Investing’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$514K Buy
83,905
+26,612
+46% +$221K 0.03% 675
2025
Q4 		$476K Buy
57,293
+25,716
+81% +$277K 0.04% 342
2025
Q3 		$460K Buy
+31,577
New +$378K 0.04% 375

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Inspire Investing's DNA Position: Q1 2026 in Review

Inspire Investing increased its Ginkgo Bioworks (DNA) stake by 46% in Q1 2026, buying an estimated $221K and bringing the position to 83,905 shares worth $514K. The position accounts for 0.03% of the portfolio, ranked #675.

Inspire Investing first reported a position in DNA in Q3 2025 and has held it in 3 quarters since. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Inspire Investing held 83,905 shares of Ginkgo Bioworks worth $514K as of Q1 2026.
  • Inspire Investing bought 26,612 Ginkgo Bioworks shares in Q1 2026, an estimated $221K.
  • Ginkgo Bioworks made up 0.03% of Inspire Investing's portfolio in Q1 2026, its #675 holding.
  • Inspire Investing first reported a position in Ginkgo Bioworks in Q3 2025 and has held it in 3 quarters since.
  • 175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.